{
    "root": "30168ea9-9be5-75bd-e063-6394a90ab409",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Famotidine",
    "value": "20250311",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FAMOTIDINE",
            "code": "5QZO15J2Z8"
        }
    ],
    "indications": "famotidine tablets indicated adult pediatric patients 40 kg greater treatment : • active duodenal ulcer ( du ) . • active gastric ulcer ( gu ) . • symptomatic nonerosive gastroesophageal reflux disease ( gerd ) . • erosive esophagitis due gerd , diagnosed biopsy . famotidine tablets indicated adults : • treatment pathological hypersecretory conditions ( e.g . , zollinger-ellison syndrome , multiple endocrine neoplasias ) . • reduction risk duodenal ulcer recurrence .",
    "contraindications": "indication recommended ( 2.1 ) adult pediatric patients 40 kg greater active du 40 mg daily ; 20 mg twice daily active gastriculcer 40 mg daily gerd 20 mg twice daily erosive esophagitis 20 mg twice daily ; or40 mg twice daily adults pathological hypersecretory conditions 20 mg every 6 hours ; adjust patient needs ; maximum 160 mg every 6 hours risk reduction du recurrence 20 mg daily • full prescribing information complete dosing information , including dosing renal impairment , recommended treatment duration . ( 2.1 , 2.2 ) ( 2.3 ) : take daily bedtime twice daily morning bedtime without food .",
    "warningsAndPrecautions": "famotidine tablets usp , 20 mg yellow , film-coated , round shaped tablets ‘ c ’ 119 one side plain side supplied bottles 60 's counts - ndc 68645-594-59. storage store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] . dispense usp tight , light-resistant container .",
    "adverseReactions": "famotidine tablets contraindicated patients history serious hypersensitivity ( e.g . , anaphylaxis ) famotidine histamine-2 ( h 2 ) receptor antagonists .",
    "indications_original": "Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of:\n                  • active duodenal ulcer (DU).\n                  • active gastric ulcer (GU).\n                  • symptomatic nonerosive gastroesophageal reflux disease (GERD).\n                  • erosive esophagitis due to GERD, diagnosed by biopsy. \n                  Famotidine tablets are indicated in adults for the:\n                  • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).\n                  • reduction of the risk of duodenal ulcer recurrence.",
    "contraindications_original": "Indication Recommended Dosage ( 2.1 ) Adult and Pediatric Patients 40 kg and greater Active DU 40 mg once daily; or 20 mg twice daily Active GastricUlcer 40 mg once daily GERD 20 mg twice daily Erosive Esophagitis 20 mg twice daily; or40 mg twice daily Adults Pathological Hypersecretory Conditions 20 mg every 6 hours; adjust to patient needs; maximum 160 mg every 6 hours Risk Reduction of DU Recurrence 20 mg once daily • See full prescribing information for complete dosing information, including dosing in renal impairment, and recommended treatment duration. ( 2.1 , 2.2 ) Administration ( 2.3 ): Take once daily before bedtime or twice daily in the morning and before bedtime with or without food.",
    "warningsAndPrecautions_original": "Famotidine tablets USP, 20 mg are yellow, film-coated, round shaped tablets with ‘C’\n                  119\n                  on one side and plain on other side and are supplied in bottles of 60's counts - NDC 68645-594-59.\n                  \n                  \n                     Storage\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].\n                  Dispense in a USP tight, light-resistant container.",
    "adverseReactions_original": "Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H\n       \n \n  2) receptor antagonists."
}